1
/
of
0
FDA Drug/Biologics Approval BLA 125521 S-009 Medical Officers Review, Statistical Review and COA Staff for: Taltz(ixekizumab), IXEKIZUMAB
FDA Drug/Biologics Approval BLA 125521 S-009 Medical Officers Review, Statistical Review and COA Staff for: Taltz(ixekizumab), IXEKIZUMAB
Regular price
$89.00 USD
Regular price
Sale price
$89.00 USD
Unit price
/
per
BLA 125521 S-009 Medical Officers Review, Statistical Review and COA Staff for: Taltz(ixekizumab)
Company: ELI LILLY AND CO
Drug Name: TALTZ
Active Ingredients: IXEKIZUMAB
Strength: 80MG/ML
Dosage Form/Route: INJECTABLE;INJECTION
Action Date: 03/22/2016
Marketing Status: Prescription
Submission Classification: ORIG-1
Company: ELI LILLY AND CO
Drug Name: TALTZ
Active Ingredients: IXEKIZUMAB
Strength: 80MG/ML
Dosage Form/Route: INJECTABLE;INJECTION
Action Date: 03/22/2016
Marketing Status: Prescription
Submission Classification: ORIG-1
Couldn't load pickup availability
- Status: Pending Fast-Track Request
- Delivery: Approximately 1 to 2 weeks when the FOIA office is operating at regular capacity
NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.
View full details